Form 4: Biofrontera Inc. Director Beth J. Hoffman Acquires Stock Options

Director Beth J. Hoffman acquired 20,000 employee stock options in Biofrontera Inc. on July 12, 2024.

Summary

• On July 12, 2024, Beth J. Hoffman, a director of Biofrontera Inc., acquired 20,000 employee stock options.
• The exercise price of these options is $1.38.
• The options vest in twelve equal monthly installments starting August 12, 2024.
• The options expire on July 12, 2034.
• Following the transaction, Hoffman directly owns 21,100 derivative securities.
• All share amounts have been adjusted for the reverse stock split that occurred on June 28, 2023.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors. It's a standard practice to ensure fair market practices and prevent insider trading.

Stakeholder Impact

• Shareholders are informed about the director's acquisition of stock options, providing transparency into management's incentives.
• The transaction could potentially impact employee morale, as it involves employee stock options.

Key Dates

Keywords

Form 4, Biofrontera Inc., BFRI, stock options, derivative securities, insider trading, Beth J. Hoffman, director